CIN 1, a low-grade intraepithelial lesion suggestive ... are high-grade lesions that have the potential to progress to invasive cervical cancer (Table I). More than 70 different HPV types have ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Cervical cancer is one of the most common cancers, and it develops due to abnormal cell growth in the cervix, triggered by persistent infection with the human papillomavirus (HPV). The common ...

Dr. Ritu Salani discusses how patients with cervical cancer can advocate for their health and collaborate with their medical team to ensure the best care.

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Cervical cancer remains one of the most challenging diseases in oncology, with high recurrence rates and significant treatment side effects. For decades, the standard approach has relied on a ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Health experts estimate that nearly 14,000 women in the U.S. will be diagnosed with cervical cancer, with more than 4,000 ...

In general, diagnostic HPV tests have to demonstrate accuracy, reproducibility and clinical utility before they can be used in patient management and implemented in cervical cancer screening ...

Dr. Nidhi Sharma Chauhan explained the treatment procedures to be followed to address cervical cancer during pregnancy.

For patients with human papillomavirus (HPV) type 16 (HPV16)-positive cervical intraepithelial neoplasia grade 3 (CIN3), vaccination with a replication-incompetent Semliki Forest virus vaccine ...

A cervical cancer drug may elevate the risk of developing ocular surface disease, such as conjunctival scarring and infectious keratitis.